BKYI · Bio Key International Inc
Substantial doubt about the company's ability to continue as a going concern.
“The history of losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations after the current cash resources are exhausted raises doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-30 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026. |
Common Stock
|
250 |
| 2026-06-30 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026. |
Common Stock
|
250 |
| 2026-06-30 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026. |
Common Stock
|
250 |
| 2025-12-31 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Holdings do not include options to purchase 87 shares. |
Common Stock
|
2,500 |
| 2025-12-31 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Holdings do not include options to purchase 174 shares and 12,667 shares issuable upon exercise of warrants. |
Common Stock
|
2,500 |
| 2025-12-31 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |
Common Stock
|
2,500 |
| 2025-09-16 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants, which were originally included in the form 4 filed earlier today. |
Common Stock
|
1,617 |
| 2025-09-15 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants, which were originally included in the form 4 filed earlier today. |
Common Stock
|
2,500 |
| 2025-09-02 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, as amended, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 87 shares. |
Common Stock
|
25,000 |
| 2025-09-02 | Welch Cecilia C |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, as amended, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 174 shares. |
Common Stock
|
35,000 |
| 2025-09-02 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, as amended, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 232 shares. |
Common Stock
|
45,000 |
| 2025-09-02 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, as amended, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 174 shares. |
Common Stock
|
40,000 |
| 2025-08-22 | Sullivan James David |
Chief Legal Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Holdings do not include options to purchase 174 shares. |
Common Stock
|
10,000 |
| 2025-06-30 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Holdings do not include options to purchase 174 shares and 12,667 shares issuable upon exercise of warrants. |
Common Stock
|
139 |
| 2025-06-30 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |
Common Stock
|
139 |
| 2025-06-30 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Holdings do not include options to purchase 87 shares. |
Common Stock
|
139 |
| 2025-06-13 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants. |
Common Stock
|
5,000 |
| 2025-06-03 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Holdings do not include options to purchase 232 shares. |
Common Stock
|
5,000 |
| 2025-06-03 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Holdings do not include options to purchase 232 shares. |
Common Stock
|
4,000 |
| 2025-05-27 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 36 shares. |
Common Stock
|
5,000 |
| 2025-05-27 | Alia Emmanuel |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 18 shares. |
Common Stock
|
5,000 |
| 2025-05-27 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. |
Common Stock
|
5,000 |
| 2025-05-27 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board committee meeting attendance fees |
Common Stock
|
1,266 |
| 2025-05-27 | Kwok Fong Wong |
Director, Managing Director, BIO-key HK |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 232 shares. |
Common Stock
|
2,000 |
| 2025-05-27 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board committee meeting attendance fees Holdings do not include options to purchase 36 shares. |
Common Stock
|
1,266 |
| 2025-05-08 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
3,897 |
| 2025-05-08 | Alia Emmanuel |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
3,897 |
| 2025-05-08 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
3,897 |
| 2025-03-20 | Alia Emmanuel |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
2,971 |
| 2025-03-20 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
2,971 |
| 2025-03-20 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
2,971 |
| 2024-12-31 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.Holdings do not include options to purchase 174 shares. |
Common Stock
|
139 |
| 2024-12-31 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 464 shares. |
Common Stock
|
139 |
| 2024-12-31 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 348 shares. |
Common Stock
|
139 |
| 2024-11-07 | Alia Emmanuel |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
2,587 |
| 2024-11-07 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
2,587 |
| 2024-11-07 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board meeting attendance fees |
Common Stock
|
2,587 |
| 2024-07-31 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 464 shares and warrants to purchase 9167 shares. |
Common Stock
|
24,000 |
| 2024-07-31 | Alia Emmanuel |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 18 shares. |
Common Stock
|
3,500 |
| 2024-07-31 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board committee meeting attendance fees |
Common Stock
|
676 |
| 2024-07-31 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 47 shares. |
Common Stock
|
3,500 |
| 2024-07-31 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 174 shares. |
Common Stock
|
9,000 |
| 2024-07-31 | Welch Cecilia C |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 348 shares. |
Common Stock
|
22,500 |
| 2024-07-31 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Holdings do not include options to purchase 348 shares and warrants to purchase 12,667 shares. |
Common Stock
|
22,500 |
| 2024-07-31 | Michel Robert J |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person under the Issuer's 2023 Stock Incentive Plan in payment of board committee meeting attendance fees Holdings do not include options to purchase 47 shares. |
Common Stock
|
676 |
| 2024-07-31 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. Restricted Stock granted to the Reporting person under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. |
Common Stock
|
3,500 |
| 2024-06-28 | Sullivan James David |
Chief Legal Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 348 shares. |
Common Stock
|
139 |
| 2024-06-28 | DEPASQUALE MICHAEL W |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 464 shares. |
Common Stock
|
139 |
| 2024-06-28 | LACOUS MIRA K |
Chief Technology Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.Holdings do not include options to purchase 174 shares. |
Common Stock
|
139 |
| 2024-03-27 | Williams Cameron E. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents shares issued to the Reporting Person on March 27, 2024 under the Issuer's Amended and Restated 2015 Equity Incentive Plan in payment of board meeting attendance fees. |
Common Stock
|
1,429 |